HeadInvest LLC’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,245
Closed -$620K 201
2019
Q3
$620K Sell
6,245
-1,945
-24% -$185K 0.19% 85
2019
Q2
$757K Sell
8,190
-3,107
-28% -$295K 0.21% 75
2019
Q1
$1.07M Sell
11,297
-11,863
-51% -$1.04M 0.3% 63
2018
Q4
$1.48M Buy
23,160
+1,450
+7% +$107K 0.24% 73
2018
Q3
$1.94M Sell
21,710
-1,190
-5% -$105K 0.56% 48
2018
Q2
$1.82M Sell
22,900
-485
-2% -$40.3K 0.55% 48
2018
Q1
$2.09M Buy
23,385
+755
+3% +$72.5K 0.67% 46
2017
Q4
$2.36M Sell
22,630
-490
-2% -$55.3K 0.73% 44
2017
Q3
$2.33M Buy
23,120
+175
+0.8% +$23.8K 0.73% 43
2017
Q2
$2.98M Buy
22,945
+140
+0.6% +$17.2K 0.98% 33
2017
Q1
$2.84M Sell
22,805
-240
-1% -$28.7K 0.95% 34
2016
Q4
$2.67M Sell
23,045
-55
-0.2% -$6.13K 0.99% 35
2016
Q3
$2.41M Buy
23,100
+1,700
+8% +$184K 0.85% 37
2016
Q2
$2.11M Buy
21,400
+775
+4% +$80.2K 0.8% 42
2016
Q1
$2.06M Buy
20,625
+1,650
+9% +$170K 0.81% 41
2015
Q4
$2.27M Buy
18,975
+845
+5% +$97.8K 0.92% 36
2015
Q3
$1.96M Buy
+18,130
New +$2.25M 0.79% 41

Other funds holding CELG

HeadInvest LLC's CELG Position: Q4 2019 in Review

HeadInvest LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,245 shares — an estimated $620K sold.

HeadInvest LLC first reported a position in CELG in Q3 2015 and held it in 17 quarters. The position peaked at $2.98M in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HeadInvest LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HeadInvest LLC sold 6,245 Celgene Corp shares in Q4 2019, an estimated $620K.
  • HeadInvest LLC first reported a position in Celgene Corp in Q3 2015 and held it in 17 quarters.
  • HeadInvest LLC's Celgene Corp position peaked at $2.98M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HeadInvest LLC's 13F filing for Q4 2019, filed 14 Feb 2020.